{"nct_id":"NCT06691984","title":"Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-12-09","start_date_type":"ACTUAL","primary_completion_date":"2028-12-01","primary_completion_date_type":"ESTIMATED","completion_date":"2029-07-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMGN"]}